-
"Clinicians at my family planning facility often refuse to give a birth control method if the patient is late for her annual exam," says a respondent to the 2010 Contraceptive Technology Update Contraception Survey.
-
Clinicians now have the latest guidance in managing patients who have, or are at risk for, sexually transmitted diseases (STDs) with the just-released 2010 STD Treatment Guidelines.
-
Despite the continued high burden of sexually transmitted infections (STIs) in the United States, an analysis of 2009 national data by the Centers for Disease Control and Prevention (CDC) shows some signs of progress on the prevention front:
-
Results of a new study suggest that nearly one in 10 sexually active teens have same-sex partners, which is almost twice as many as previous research studies have found.
-
Results of a new study indicate fasting glucose and insulin levels remain within normal range for women using injectable or oral contraception, with only slight increases among women using depot medroxyprogesterone acetate (DMPA).
-
Clinician office phones might be ringing following news reports of women in the United Kingdom (UK) who experienced unintended pregnancies while using the contraceptive implant Implanon. How do you counsel women on this form of long-acting contraception?
-
-
The occurrence of skin rash in patients receiving cetuximab is common, and for patients with colon cancer, this has been associated with better clinical outcomes.
-
Very limited data are available on autologous transplant outcomes for uncommon or rare multiple myeloma (MM) subtypes.
-
With the development of an increased understanding of cellular biology, in general, and the regulation of eosinophils, in particular, the heterogeneous diagnosis of hypereosinophilic Syndrome (HES) has now been better defined and a classification system has been developed with clear clinical implications.